97088 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Protease inhibitors; Endopeptidase (E.C. 3.4.21-99) inhibitors; Serine protease (E.C. 3.4.21) inhibitors; Serpins Antithrombin III
PLASMA FRACTIONATION UTILIZING SPRAY-DRIED HUMAN PLASMA
#2Treatment of infection by human enterovirus D68
#3TREATMENT OF INFECTION BY HUMAN ENTEROVIRUS D68
#4PRE-TREATMENT AGENT AND PRE-TREATMENT METHOD FOR ANTITHROMBIN III TO BE SUBJECTED TO LIMULUS TEST
#5Class of therapeutic protein based molecules
#6Treatment of infection by human enterovirus D68
#7Methods for detecting levels of pigment epithelium-derived factor and antithrombin-III for characterising and/or prognosing prostate cancer
#8Class of therapeutic protein based molecules
#9Pre-treatment agent and pre-treatment method for antithrombin III to be subjected to limulus test
#10Class of therapeutic protein based molecules
#11Method for purifying protein
#12Serpin-finger fusion polypeptide
#13Class of therapeutic protein based molecules
#14Methods for modeling protein stability
#15Method for producing proteins in that lack detectable cross binding activity to antibodies against host cell antigens
#16Mutated antithrombins, a process for preparing the same and their use as drugs
#17Class of therapeutic protein based molecules
#18Use of mutated antithrombins for treating or preventing coagulation disorders
#19Preparation of low bleeding anticoagulant fusion protein and its use
#20Method for producing antithrombin composition
#21Preparation of low bleeding anticoagulant fusion protein and its use
#22Antimicrobial peptides with heparin binding activity
#23Compositions and methods for regulating apoptosis
#24Transgenically produced antithrombin III
#25Methods of Using High Affinity Atiii Variants
#26Novel antimicrobial peptides with heparin binding activity
#27Compositions and methods for regulating apoptosis
#28Method of purifying recombinant human antithrombin to enhance the viral and prion safety profile
#29Variants of antithrombin III
#30Protein S protects the nervous system from injury
#31Method of producing recombinant antithrombin III composition
#32Filtration
#33Use of coagulant-active antithrombin iii for the therapy of angiogenesis-dependent diseases
#34Expression of dominant negative transmembrane receptors in the milk of transgenic animals
#35Human antithrombin IIIs and methods related thereto